The decline in Abbott Laboratories' stock price is likely due to the Q4 financial results and guidance not aligning with market expectations. Financial results and forward guidance are critical factors in a stock's performance, and any perceived weakness or uncertainty can lead to a decrease in share value. The immediate negative reaction suggests that the results or guidance were below analyst predictions or investor hopes, prompting a sell-off.